{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:16:42Z","timestamp":1792718202929,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FU 356\/12-1"],"award-info":[{"award-number":["FU 356\/12-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010068","name":"Medizinische Fakult\u00e4t, Universit\u00e4t Duisburg-Essen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jcf.2021.05.001","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T15:20:14Z","timestamp":1621610414000},"page":"1072-1079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4603-6602","authenticated-orcid":false,"given":"Dirk","family":"Westh\u00f6lter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Beckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Stra\u00dfburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Welsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivagurunathan","family":"Sutharsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3546-1398","authenticated-orcid":false,"given":"Christian","family":"Taube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jcf.2021.05.001_bib0001","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.3390\/ijms21176379","article-title":"Airway inflammation and host responses in the era of CFTR modulators","volume":"21","author":"Keown","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.jcf.2021.05.001_bib0002","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201708-1616OC","article-title":"Infection is not required for mucoinflammatory lung disease in CFTR-knockout ferrets","volume":"197","author":"Rosen","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcf.2021.05.001_bib0003","first-page":"1075","article-title":"Early pulmonary inflammation in infants with cystic fibrosis","volume":"151","author":"Khan","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcf.2021.05.001_bib0004","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1159\/000446825","article-title":"Cystic fibrosis lung immunity: the role of the macrophage","volume":"8","author":"Bruscia","year":"2016","journal-title":"J Innate Immun"},{"issue":"4","key":"10.1016\/j.jcf.2021.05.001_bib0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jcf.2017.03.007","article-title":"Monocyte derived macrophages from CF pigs exhibit increased inflammatory responses at birth","volume":"16","author":"Paemka","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2021.05.001_bib0006","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/hsz-2015-0271","article-title":"Neutrophils in cystic fibrosis","volume":"397","author":"Laval","year":"2016","journal-title":"Biol Chem"},{"issue":"1","key":"10.1016\/j.jcf.2021.05.001_bib0007","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12931-019-1103-1","article-title":"CFTR regulates B cell activation and lymphoid follicle development","volume":"20","author":"Polverino","year":"2019","journal-title":"Respir Res"},{"issue":"2","key":"10.1016\/j.jcf.2021.05.001_bib0008","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.201102-0236OC","article-title":"The Th17 pathway in cystic fibrosis lung disease","volume":"184","author":"Tan","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcf.2021.05.001_bib0009","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.201206-1150OC","article-title":"A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection","volume":"187","author":"Tiringer","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jcf.2021.05.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120912","article-title":"High peripheral blood Th17 percent associated with poor lung function in cystic fibrosis","volume":"10","author":"Mulcahy","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jcf.2021.05.001_bib0011","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-3083.2009.02308.x","article-title":"How do regulatory T cells work?","volume":"70","author":"Corthay","year":"2009","journal-title":"Scand J Immunol"},{"issue":"8","key":"10.1016\/j.jcf.2021.05.001_bib0012","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1164\/rccm.201407-1381OC","article-title":"Regulatory T-cell impairment in cystic fibrosis patients with chronic Pseudomonas infection","volume":"191","author":"Hector","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcf.2021.05.001_bib0013","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/08820139.2014.888447","article-title":"CD4+CD25 high FOXP3+ Regulatory T cells correlate with FEV1 in North Indian children with cystic fibrosis","volume":"43","author":"Anil","year":"2014","journal-title":"Immunol Invest"},{"issue":"1","key":"10.1016\/j.jcf.2021.05.001_bib0014","doi-asserted-by":"crossref","first-page":"A36","DOI":"10.1186\/1753-6561-9-S1-A36","article-title":"The importance of CFTR expression for neutrophil function in patients with cystic fibrosis","volume":"9","author":"Jundi","year":"2015","journal-title":"BMC Proc"},{"issue":"1","key":"10.1016\/j.jcf.2021.05.001_bib0015","doi-asserted-by":"crossref","first-page":"17066","DOI":"10.1038\/s41598-018-35151-7","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jcf.2021.05.001_bib0016","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1165\/rcmb.2010-0224OC","article-title":"Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses","volume":"44","author":"Mueller","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1016\/j.jcf.2021.05.001_bib0017","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1016\/S0021-9258(19)50722-0","article-title":"Human lymphocytes transcribe the cystic fibrosis transmembrane conductance regulator gene and exhibit CF-defective cAMP-regulated chloride current","volume":"267","author":"McDonald","year":"1992","journal-title":"J Biol Chem"},{"issue":"19","key":"10.1016\/j.jcf.2021.05.001_bib0018","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013tezacaftor\u2013ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.jcf.2021.05.001_bib0019","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2021.05.001_bib0020","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3389\/fphar.2020.01219","article-title":"CFTR modulator therapy enhances peripheral blood monocyte contributions to immune responses in people with cystic fibrosis","volume":"11","author":"Hisert","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcf.2021.05.001_bib0021","doi-asserted-by":"crossref","unstructured":"Jarosz-Griffiths HH, Scambler T, Wong CH, et\u00a0al. Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis. In Rath S, van der Meer JWM, Coll R, Bekkering S, eds. Elife. 2020;9:e54556. doi:10.7554\/eLife.54556.","DOI":"10.7554\/eLife.54556"},{"issue":"8","key":"10.1016\/j.jcf.2021.05.001_bib0022","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3390\/ijms17081316","article-title":"Development of a modular assay for detailed immunophenotyping of peripheral human whole blood samples by multicolor flow cytometry","volume":"17","author":"R\u00fchle","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"129","key":"10.1016\/j.jcf.2021.05.001_bib0023","first-page":"56440","article-title":"Multiplex cytokine profiling of stimulated mouse splenocytes using a cytometric bead-based immunoassay platform","author":"Lehmann","year":"2017","journal-title":"J Vis Exp"},{"issue":"6","key":"10.1016\/j.jcf.2021.05.001_bib0024","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/cmi.2016.30","article-title":"Human CD39hi regulatory T cells present stronger stability and function under inflammatory conditions","volume":"14","author":"Gu","year":"2017","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"10.1016\/j.jcf.2021.05.001_bib0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1164\/rccm.201207-1346OC","article-title":"Th17\/Treg imbalance in murine cystic fibrosis Is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines","volume":"187","author":"Iannitti","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.jcf.2021.05.001_bib0026","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.4049\/jimmunol.1202283","article-title":"Systemic flagellin immunization stimulates mucosal CD103+ dendritic cells and drives Foxp3+ regulatory T cell and IgA responses in the mesenteric lymph node","volume":"189","author":"Flores-Langarica","year":"2012","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jcf.2021.05.001_bib0027","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/01902148.2014.964351","article-title":"Regulatory T cell activity is partly inhibited in a mouse model of chronic Pseudomonas aeruginosa lung infection","volume":"41","author":"Ding","year":"2015","journal-title":"Exp Lung Res"},{"issue":"12","key":"10.1016\/j.jcf.2021.05.001_bib0028","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1164\/rccm.201609-1954OC","article-title":"Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jcf.2021.05.001_bib0029","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1034\/j.1600-0463.2000.d01-64.x","article-title":"The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type","volume":"108","author":"Moser","year":"2000","journal-title":"APMIS"},{"issue":"1","key":"10.1016\/j.jcf.2021.05.001_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12890-018-0630-8","article-title":"Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis","volume":"18","author":"Sch\u00e4fer","year":"2018","journal-title":"BMC Pulm Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199321001284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199321001284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:45:16Z","timestamp":1761601516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199321001284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1569199321001284"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2021.05.001","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2021.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}